Toll-like receptors are crucial in modulating immune responses. Glycogen synthase kinase 3 is involved in Toll-like receptor signaling and regulates the production of proinflammatory cytokines and septic shock.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study
Schizophrenia Open Access 14 October 2023
-
Escitalopram Ameliorates Cognitive Impairment in D-Galactose-Injected Ovariectomized Rats: Modulation of JNK, GSK-3β, and ERK Signalling Pathways
Scientific Reports Open Access 11 July 2019
-
The ubiquitin ligase ZNRF1 promotes caveolin-1 ubiquitination and degradation to modulate inflammation
Nature Communications Open Access 08 June 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A. Jr . Nature 388, 394–397 (1997).
Janeway, C.A. Jr . Immunol. Today 13, 11–16 (1992).
Iwasaki, A. & Medzhitov, R. Nat. Immunol. 5, 987–995 (2004).
Moser, M. & Murphy, K.M. Nat. Immunol. 1, 199–205 (2000).
Akira, S. & Takeda, K. Nat. Rev. Immunol. 4, 499–511 (2004).
Martin, M., Rehani, K., Jope, R. & Michalek, S.M. Nat. Immunol. 6, 777–784 (2005).
Fukao, T. & Koyasu, S. Trends Immunol. 24, 358–363 (2003).
Fukao, T. et al. Nat. Immunol. 3, 875–881 (2002).
Doble, B.W. & Woodgett, J.R. J. Cell Sci. 116, 1175–1186 (2003).
Andreakos, E., Foxwell, B. & Feldmann, M. Immunol. Rev. 202, 250–265 (2004).
Cohen, P. & Goedert, M. Nat. Rev. Drug Discov. 3, 479–487 (2004).
Hoeflich, K.P. et al. Nature 40, 86–90 (2000).
Beals, C.R., Sheridan, C.M., Turck, C.W., Gardner, P. & Crabtree, G.R. Science 275, 1930–1934 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woodgett, J., Ohashi, P. GSK3: an in-Toll-erant protein kinase?. Nat Immunol 6, 751–752 (2005). https://doi.org/10.1038/ni0805-751
Issue Date:
DOI: https://doi.org/10.1038/ni0805-751
This article is cited by
-
Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study
Schizophrenia (2023)
-
Escitalopram Ameliorates Cognitive Impairment in D-Galactose-Injected Ovariectomized Rats: Modulation of JNK, GSK-3β, and ERK Signalling Pathways
Scientific Reports (2019)
-
The ubiquitin ligase ZNRF1 promotes caveolin-1 ubiquitination and degradation to modulate inflammation
Nature Communications (2017)
-
Inhibition of the phosphoinositide 3-kinase pathway decreases innate resistance to lipopolysaccharide toxicity in TLR4 deficient mice
Journal of Biomedical Science (2014)
-
An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection
Journal of Biomedical Science (2013)